We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

34 hedge funds and large institutions have $143M invested in Assembly Biosciences in 2015 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 2

326% more capital invested

Capital invested by funds: $33.4M → $143M (+$109M)

250% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 4

42% more funds holding

Funds holding: 24 → 34 (+10)

Holders
34
Holders Change
+10
Holders Change %
+41.67%
% of All Funds
0.91%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
14
Increased
12
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$15.2M
2
Jennison Associates
Jennison Associates
New York
+$12.4M
3
VAM
Visium Asset Management
New York
+$7.51M
4
EC
EcoR1 Capital
California
+$6.36M
5
HM
HealthCor Management
New York
+$5.36M

Top Sellers

Rank Fund Capital Flow
1
ACP
Acuta Capital Partners
California
-$30K
2
TRCT
Tower Research Capital (TRC)
New York
-$17.9K
3
Citigroup
Citigroup
New York
-$13K
4
UBS Group
UBS Group
Switzerland
-$5K
5
BRWA
B. Riley Wealth Advisors
Florida
-$30
Name Holding Trade Value Shares
Change 		Change in
Stake
Jennison Associates
1
Jennison Associates
New York
$26.4M +$12.4M +91,834 +123%
EC
2
EcoR1 Capital
California
$20.8M +$6.36M +47,030 +56%
VAM
3
Visium Asset Management
New York
$19.9M +$7.51M +55,476 +80%
O
4
OrbiMed
New York
$17.9M +$15.2M +112,500 New
QF
5
QVT Financial
New York
$7.08M – – –
HM
6
HealthCor Management
New York
$6.29M +$5.36M +39,583 New
PA
7
Perceptive Advisors
New York
$5.63M +$4.79M +35,417 New
Millennium Management
8
Millennium Management
New York
$5.32M +$3.42M +25,272 +308%
PI
9
Putnam Investments
Massachusetts
$4.9M +$4.17M +30,833 New
RSCM
10
Rock Springs Capital Management
Maryland
$4.2M +$3.58M +26,458 New
Vanguard Group
11
Vanguard Group
Pennsylvania
$4.16M +$2.12M +15,650 +148%
BIT
12
BlackRock Institutional Trust
California
$3.55M +$67.2K +497 +2%
BBA
13
Baker Bros. Advisors
New York
$3.31M +$2.82M +20,833 New
RI
14
RTW Investments
New York
$2.7M – – –
IHM
15
Iguana Healthcare Management
New York
$1.99M +$1.13M +8,333 +200%
GTC
16
Ghost Tree Capital
New York
$1.66M +$676K +5,000 +92%
Fidelity Investments
17
Fidelity Investments
Massachusetts
$1.32M – – –
SFM
18
Sphera Funds Management
Israel
$1.32M +$1.13M +8,333 New
OPPM
19
Opus Point Partners Management
New York
$861K +$733K +5,417 New
Geode Capital Management
20
Geode Capital Management
Massachusetts
$771K +$239K +1,766 +57%
MIM
21
Monashee Investment Management
Massachusetts
$636K +$541K +4,000 New
Morgan Stanley
22
Morgan Stanley
New York
$405K +$20.2K +149 +6%
Renaissance Technologies
23
Renaissance Technologies
New York
$320K +$55.2K +408 +25%
Tudor Investment Corp
24
Tudor Investment Corp
Connecticut
$314K +$268K +1,979 New
Goldman Sachs
25
Goldman Sachs
New York
$238K +$82.4K +609 +69%
1
2

ASMB Hedge Fund Activity: Q1 2015 in Review

34 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q1 2015, worth a combined $143M — up 326% from $33.4M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ASMB positions and 4 closed out — a net gain of 10 holders — while 12 added to existing stakes and 2 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $15.2M. The largest seller was Acuta Capital Partners, exiting entirely with an estimated $30K sold.

  • 34 institutional investors held Assembly Biosciences (ASMB) as of Q1 2015, up from 24 in Q4 2014.
  • Funds reported $143M of Assembly Biosciences stock for Q1 2015, up 326% quarter-over-quarter.
  • 14 funds opened new Assembly Biosciences positions in Q1 2015 and 4 closed out, a net change of +10 holders.
  • The largest Assembly Biosciences buyer in Q1 2015 was OrbiMed, an estimated $15.2M added.
  • The largest Assembly Biosciences seller in Q1 2015 was Acuta Capital Partners, an estimated $30K sold.

Based on aggregated 13F filings for Q1 2015.